{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T19:27:44Z","timestamp":1771010864529,"version":"3.50.1"},"reference-count":48,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003134","name":"Fonds pour la Formation \u00e0 la Recherche dans l\u2019Industrie et dans l\u2019Agriculture","doi-asserted-by":"publisher","award":["FC005053"],"award-info":[{"award-number":["FC005053"]}],"id":[{"id":"10.13039\/501100003134","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","rbmojournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reproductive BioMedicine Online"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.rbmo.2018.04.050","type":"journal-article","created":{"date-parts":[[2018,5,7]],"date-time":"2018-05-07T13:16:09Z","timestamp":1525698969000},"page":"224-233","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Gene expression changes in uterine myomas in response to ulipristal acetate treatment"],"prefix":"10.1016","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9311-2105","authenticated-orcid":false,"given":"Guillaume E.","family":"Courtoy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacques","family":"Donnez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00e9r\u00f4me","family":"Ambroise","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo","family":"Arriagada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3687-3001","authenticated-orcid":false,"given":"Mathieu","family":"Luyckx","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Etienne","family":"Marbaix","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Madeleine","family":"Dolmans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rbmo.2018.04.050_bib0010","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ygyno.2014.04.012","article-title":"A high-throughput open-array qPCR gene panel to identify housekeeping genes suitable for myometrium and leiomyoma expression analysis","volume":"134","author":"Almeida","year":"2014","journal-title":"Gynecol. Oncol"},{"key":"10.1016\/j.rbmo.2018.04.050_bib0015","first-page":"1495","article-title":"Expression of matricellular proteins in human uterine leiomyomas and normal myometrium","volume":"27","author":"Bogusiewicz","year":"2012","journal-title":"Histol. Histopathol"},{"key":"10.1016\/j.rbmo.2018.04.050_bib0020","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1093\/humrep\/dem216","article-title":"Progesterone withdrawal up-regulates fibronectin and integrins during menstruation and repair in the rhesus macaque endometrium","volume":"22","author":"Cao","year":"2007","journal-title":"Hum. Reprod"},{"key":"10.1016\/j.rbmo.2018.04.050_bib0025","doi-asserted-by":"crossref","first-page":"E837","DOI":"10.1210\/jc.2012-3647","article-title":"Overexpression of integrin-beta1 in leiomyoma promotes cell spreading and proliferation","volume":"98","author":"Chen","year":"2013","journal-title":"J. Clin. Endocrinol. Metab"},{"key":"10.1016\/j.rbmo.2018.04.050_bib0030","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1093\/humupd\/dmv030","article-title":"Epidemiological and genetic clues for molecular mechanisms involved in uterine leiomyoma development and growth","volume":"21","author":"Commandeur","year":"2015","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.rbmo.2018.04.050_bib0035","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.fertnstert.2015.04.025","article-title":"In vivo mechanisms of uterine myoma volume reduction with ulipristal acetate treatment","volume":"104","author":"Courtoy","year":"2015","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2018.04.050_bib0040","article-title":"Progesterone receptor isoforms, nuclear cofactors NCoR1 and SRC1, and Bcl-2 and Akt\/p-Akt in uterine myomas after ulipristal acetate treatment: a systematic immunohistochemical evaluation","author":"Courtoy","year":"2017","journal-title":"Gynecol. Obstet. Invest"},{"key":"10.1016\/j.rbmo.2018.04.050_bib0045","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1210\/jc.2017-02295","article-title":"Matrix metalloproteinase activity correlates with uterine myoma volume reduction after ulipristal acetate treatment","volume":"103","author":"Courtoy","year":"2018","journal-title":"J. Clin. Endocrinol. Metab"},{"key":"10.1016\/j.rbmo.2018.04.050_bib0050","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nature01283","article-title":"NF-kappaB blockade and oncogenic Ras trigger invasive human epidermal neoplasia","volume":"421","author":"Dajee","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.rbmo.2018.04.050_bib0055","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1471-2164-6-59","article-title":"Gene expression levels assessed by oligonucleotide microarray analysis and quantitative real-time RT-PCR \u2013 how well do they correlate?","volume":"6","author":"Dallas","year":"2005","journal-title":"BMC Genomics"},{"key":"10.1016\/j.rbmo.2018.04.050_bib0060","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/humupd\/dmw023","article-title":"Uterine fibroid management: from the present to the future","volume":"22","author":"Donnez","year":"2016","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.rbmo.2018.04.050_bib0065","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1056\/NEJMoa1103182","article-title":"Ulipristal acetate versus placebo for fibroid treatment before surgery","volume":"366","author":"Donnez","year":"2012","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.rbmo.2018.04.050_bib0070","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1056\/NEJMoa1103180","article-title":"Ulipristal acetate versus leuprolide acetate for uterine fibroids","volume":"366","author":"Donnez","year":"2012","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.rbmo.2018.04.050_bib0075","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/j.fertnstert.2014.02.008","article-title":"Long-term treatment of uterine fibroids with ulipristal acetate","volume":"101","author":"Donnez","year":"2014","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2018.04.050_bib0080","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1097\/GCO.0000000000000229","article-title":"Current management of myomas: the place of medical therapy with the advent of selective progesterone receptor modulators","volume":"27","author":"Donnez","year":"2015","journal-title":"Curr. Opin. Obstet. Gynecol"},{"key":"10.1016\/j.rbmo.2018.04.050_bib0085","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.fertnstert.2015.09.032","article-title":"Long-term medical management of uterine fibroids with ulipristal acetate","volume":"105","author":"Donnez","year":"2016","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2018.04.050_bib0090","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1093\/molehr\/gau022","article-title":"The CD24hi smooth muscle subpopulation is the predominant fraction in uterine fibroids","volume":"20","author":"Drosch","year":"2014","journal-title":"Mol. Hum. Reprod"},{"key":"10.1016\/j.rbmo.2018.04.050_bib0095","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-2199-15-9","article-title":"Validation of housekeeping gene and impact on normalized gene expression in clear cell renal cell carcinoma: critical reassessment of YBX3\/ZONAB\/CSDA expression","volume":"15","author":"Dupasquier","year":"2014","journal-title":"BMC Mol. Biol"},{"key":"10.1016\/j.rbmo.2018.04.050_bib0100","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1210\/en.2009-1225","article-title":"Progesterone is essential for maintenance and growth of uterine leiomyoma","volume":"151","author":"Ishikawa","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.rbmo.2018.04.050_bib0105","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1002\/humu.22612","article-title":"Mutations in Exon 1 highlight the role of MED12 in uterine leiomyomas","volume":"35","author":"Kampjarvi","year":"2014","journal-title":"Hum. Mutat"},{"key":"10.1016\/j.rbmo.2018.04.050_bib0110","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.bbadis.2011.12.015","article-title":"delta-Catenin promotes E-cadherin processing and activates beta-catenin-mediated signaling: implications on human prostate cancer progression","volume":"1822","author":"Kim","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.rbmo.2018.04.050_bib0115","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.mce.2011.05.044","article-title":"The role of progesterone signaling in the pathogenesis of uterine leiomyoma","volume":"358","author":"Kim","year":"2012","journal-title":"Mol. Cell. Endocrinol"},{"key":"10.1016\/j.rbmo.2018.04.050_bib0120","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ajog.2005.12.059","article-title":"A new hypothesis about the origin of uterine fibroids based on gene expression profiling with microarrays","volume":"195","author":"Leppert","year":"2006","journal-title":"Am. J. Obstet. Gynecol"},{"key":"10.1016\/j.rbmo.2018.04.050_bib0125","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.ajog.2016.02.049","article-title":"Long-term nonsurgical control with ulipristal acetate of multiple uterine fibroids, enabling pregnancy","volume":"214","author":"Luyckx","year":"2016","journal-title":"Am. J. Obstet. Gynecol"},{"key":"10.1016\/j.rbmo.2018.04.050_bib0130","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.matbio.2012.09.005","article-title":"Integrin beta1 regulates leiomyoma cytoskeletal integrity and growth","volume":"31","author":"Malik","year":"2012","journal-title":"Matrix Biol"},{"key":"10.1016\/j.rbmo.2018.04.050_bib0135","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1093\/bioinformatics\/btu239","article-title":"On non-detects in qPCR data","volume":"30","author":"McCall","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.rbmo.2018.04.050_bib0140","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1056\/NEJMoa1302736","article-title":"Characterization of uterine leiomyomas by whole-genome sequencing","volume":"369","author":"Mehine","year":"2013","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.rbmo.2018.04.050_bib0145","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.fertnstert.2014.06.050","article-title":"Genomics of uterine leiomyomas: insights from high-throughput sequencing","volume":"102","author":"Mehine","year":"2014","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2018.04.050_bib0150","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1073\/pnas.1518752113","article-title":"Integrated data analysis reveals uterine leiomyoma subtypes with distinct driver pathways and biomarkers","volume":"113","author":"Mehine","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.rbmo.2018.04.050_bib0155","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.1172\/JCI81534","article-title":"Med12 gain-of-function mutation causes leiomyomas and genomic instability","volume":"125","author":"Mittal","year":"2015","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.rbmo.2018.04.050_bib0160","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1038\/onc.2014.89","article-title":"delta-Catenin, a Wnt\/beta-catenin modulator, reveals inducible mutagenesis promoting cancer cell survival adaptation and metabolic reprogramming","volume":"34","author":"Nopparat","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.rbmo.2018.04.050_bib0165","doi-asserted-by":"crossref","first-page":"17053","DOI":"10.1073\/pnas.1313650110","article-title":"Paracrine activation of WNT\/beta-catenin pathway in uterine leiomyoma stem cells promotes tumor growth","volume":"110","author":"Ono","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.rbmo.2018.04.050_bib0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cancergencyto.2004.08.025","article-title":"Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: leiomyoma","volume":"158","author":"Sandberg","year":"2005","journal-title":"Cancer Genet. Cytogenet"},{"key":"10.1016\/j.rbmo.2018.04.050_bib0175","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1210\/jc.2006-0898","volume":"92","author":"Sasaki","year":"2007","journal-title":"J. Clin. Endocrinol. Metab"},{"key":"10.1016\/j.rbmo.2018.04.050_bib0180","doi-asserted-by":"crossref","first-page":"3792","DOI":"10.1210\/en.2009-0015","article-title":"Metalloproteinase-dependent shedding of low-density lipoprotein receptor-related protein-1 ectodomain decreases endocytic clearance of endometrial matrix metalloproteinase-2 and -9 at menstruation","volume":"150","author":"Selvais","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.rbmo.2018.04.050_bib0185","series-title":"Bioinformatics and Computational Biology Solutions using R and Bioconductor","first-page":"397","article-title":"Limma: linear models for microarray data","author":"Smyth","year":"2005"},{"key":"10.1016\/j.rbmo.2018.04.050_bib0190","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1146\/annurev.cellbio.17.1.463","article-title":"How matrix metalloproteinases regulate cell behavior","volume":"17","author":"Sternlicht","year":"2001","journal-title":"Annu. Rev. Cell Dev. Biol"},{"key":"10.1016\/j.rbmo.2018.04.050_bib0195","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1056\/NEJMcp1411029","article-title":"Clinical practice. Uterine fibroids","volume":"372","author":"Stewart","year":"2015","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.rbmo.2018.04.050_bib0200","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/1477-7827-7-150","article-title":"Genes targeted by the estrogen and progesterone receptors in the human endometrial cell lines HEC1A and RL95-2","volume":"7","author":"Tamm","year":"2009","journal-title":"Reprod. Biol. Endocrinol"},{"key":"10.1016\/j.rbmo.2018.04.050_bib0205","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.biocel.2015.06.003","article-title":"Tenascin-C: Its functions as an integrin ligand","volume":"65","author":"Tucker","year":"2015","journal-title":"Int. J. Biochem. Cell Biol"},{"key":"10.1016\/j.rbmo.2018.04.050_bib0210","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1093\/molehr\/gau015","article-title":"Gene expression in human ovarian tissue after xenografting","volume":"20","author":"Van Langendonckt","year":"2014","journal-title":"Mol. Hum. Reprod"},{"key":"10.1016\/j.rbmo.2018.04.050_bib0215","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2002-3-7-research0034","article-title":"Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes","volume":"3","author":"Vandesompele","year":"2002","journal-title":"Genome Biol"},{"key":"10.1016\/j.rbmo.2018.04.050_bib0220","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1210\/jc.2004-1569","article-title":"Progesterone receptor modulator CDB-2914 down-regulates proliferative cell nuclear antigen and Bcl-2 protein expression and up-regulates caspase-3 and poly(adenosine 5'-diphosphate-ribose) polymerase expression in cultured human uterineeiomyoma cells","volume":"90","author":"Xu","year":"2005","journal-title":"J. Clin. Endocrinol. Metab"},{"key":"10.1016\/j.rbmo.2018.04.050_bib0225","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/molehr\/gan004","article-title":"Progesterone receptor modulator CDB-2914 induces extracellular matrix metalloproteinase inducer in cultured human uterine leiomyoma cells","volume":"14","author":"Xu","year":"2008","journal-title":"Mol. Hum. Reprod"},{"key":"10.1016\/j.rbmo.2018.04.050_bib0230","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.fertnstert.2016.10.035","article-title":"Highly heterogeneous genomic landscape of uterine leiomyomas by whole exome sequencing and genome-wide arrays","volume":"107","author":"Yatsenko","year":"2017","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2018.04.050_bib0235","article-title":"Genome-wide progesterone receptor binding: cell type-specific and shared mechanisms in T47D breast cancer cells and primary leiomyoma cells","volume":"7","author":"Yin","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.rbmo.2018.04.050_bib0240","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ejogrb.2015.05.022","article-title":"Changes in proliferating and apoptotic markers of leiomyoma following treatment with a selective progesterone receptor modulator or gonadotropin-releasing hormone agonist","volume":"191","author":"Yun","year":"2015","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol"},{"key":"10.1016\/j.rbmo.2018.04.050_bib0245","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1476-4598-8-19","article-title":"delta-Catenin promotes prostate cancer cell growth and progression by altering cell cycle and survival gene profiles","volume":"8","author":"Zeng","year":"2009","journal-title":"Mol. Cancer"}],"container-title":["Reproductive BioMedicine Online"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472648318302578?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472648318302578?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:15:14Z","timestamp":1761466514000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472648318302578"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S1472648318302578"],"URL":"https:\/\/doi.org\/10.1016\/j.rbmo.2018.04.050","relation":{},"ISSN":["1472-6483"],"issn-type":[{"value":"1472-6483","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gene expression changes in uterine myomas in response to ulipristal acetate treatment","name":"articletitle","label":"Article Title"},{"value":"Reproductive BioMedicine Online","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rbmo.2018.04.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}